SunTerra Capital ^Investors

SunTerra Capital is an organization that focuses on investing in disruptive technology enterprises both domestically and internationally. Their main goal is to promote the commercialization of these technologies in the Chinese market and have an impact on China and the world. They have invested in Shanghai Sinobioway Sunterra, a biotechnology company that specializes in tumor cell immunotherapy. SunTerra Capital has also established Sunterra International Capital Limited, a company based in BVI, for overseas investments and asset management. Additionally, they have partnered with Beijing Hengyu Tianze Investment Management Co., Ltd. to provide financing and equity investment management services.